Elanco

Elanco

Pharmaceutical Manufacturing

Greenfield, IN 292,498 followers

Making life better for animals, makes life better.

About us

At Elanco, we work to improve the health of animals through innovative products and services for pets and farm animals around the world. As a global animal health company, we provide solutions that empower our customers to advance a vision of Food and Companionship Enriching Life. Since 1954, Elanco has committed to empowering veterinarians, farmers, and all those who care for animals with the tools they need to help animals live healthy lives. Healthier animals are the key to making our lives better - This is the fundamental belief uniting all global Elanco employees. That’s why we are committed to the idea that our business can be a unique force for good for all in society. Through our Elanco Healthy Purpose™ framework of Environmental, Social and Governance (ESG) commitments, we focus on delivering sustainable solutions to advance the well-being of animals, people and the planet. This program also enables our employees around the world to take paid time off to make an impact as a volunteer, offering their time or talent to give back to our customers, causes and communities. #ElancoHealthyPurpose #WeAreElanco

Website
http://www.elanco.com
Industry
Pharmaceutical Manufacturing
Company size
5,001-10,000 employees
Headquarters
Greenfield, IN
Type
Public Company
Specialties
Food Safety, Food Production, Animal Health, and Pets

Locations

Employees at Elanco

Updates

  • View organization page for Elanco, graphic

    292,498 followers

    Being a kitten can be scary. There are fleas, ticks, worms and as they get older, there could be pain, chronic kidney disease or even feline diabetes. But kittens, and cats of all ages, should have no fear. Our feline product portfolio has solutions to help prevent and treat these issues - allowing our beloved kittens to go about their day without a care in the world, after they take a selfie, of course. #NationalKittenDay #WeAreElanco

    • No alternative text description for this image
  • View organization page for Elanco, graphic

    292,498 followers

    As we continue to narrow our focus on the most significant value creation opportunities, we are pleased to share that we have completed the divestiture of our aqua business to Merck Animal Health for $1.3 billion in cash. This significant step allows us to concentrate on pet health and livestock sustainability, while creating balance sheet flexibility. This transaction, along with increased free cash flow from our operations, accelerates our debt reduction, positioning us to deliver substantial value over time. We expect to pay down $1.33 to $1.42 billion of debt in 2024, ending the year with net debt to adjusted EBITDA in the mid-4x range. As we continue our positive trajectory with three consecutive quarters of underlying revenue growth, and meaningful pipeline progress, we're excited for our next era of growth and innovation! #WeAreElanco https://bit.ly/3RVc3Q8

    Elanco Completes Sale of Aqua Business

    Elanco Completes Sale of Aqua Business

    elanco.com

  • View organization page for Elanco, graphic

    292,498 followers

    To feed a growing population, many factors must be addressed including food safety, animal welfare and sustainability – economic, environmental, social and cultural. Our team was recently a sponsor of the 16th European Poultry Congress (EPC) in Valencia, Spain to discuss how the poultry industry, with help from our innovative product portfolio, can be part of the solution in solving some of these challenges while giving consumers the protein they want. Along with being able to connect with customers at our Elanco booth, the team was highlighted as part of keynote speeches and events. #WeAreElanco

    • No alternative text description for this image
    • No alternative text description for this image
  • View organization page for Elanco, graphic

    292,498 followers

    Our own Dr. Jennifer Miller, Technical Veterinarian, recently discussed with K9Magazine the first-ever online canine parvovirus tracking tool, ParvoTrack – powered by Elanco. This website allows users to see the number of parvo cases reported in their area, self-report new cases and sign up to receive outbreak alerts. “ParvoTrack empowers pet owners and the veterinary community by making data more accessible to better protect dogs,” said Dr. Miller to K9Magazine. “We hope ParvoTrack, and its interactive and user-friendly interface, will serve as a catalyst in our mission to save 1 million puppies from parvo by 2030.” https://lnkd.in/g3Xg6utm #WeAreElanco

    • No alternative text description for this image
  • View organization page for Elanco, graphic

    292,498 followers

    As part of our continuous improvement of products and innovation, it’s important for our teams to connect directly with customers and industry professionals. Recently at The Poultry Federation Annual Poultry Festival, our poultry team connected with industry leaders, shared our innovations, and celebrated the achievements within the poultry community. Visitors to the Elanco booth were able to learn more about our commitment to advancing poultry health and sustainability through our innovative product portfolio - working together to help raise healthy poultry. #WeAreElanco #PoultryHealth #Sustainability

    • No alternative text description for this image
    • No alternative text description for this image
  • View organization page for Elanco, graphic

    292,498 followers

    Today we announced updates to the expected U.S. Food and Drug Administration (FDA) approval timelines for Zenrelia and Credelio Quattro. Elanco is largely on track with our blockbuster approvals with U.S. Zenrelia approval expected in the third quarter and Credelio Quattro now shifting to the fourth quarter. We also provided additional context on Zenrelia, sharing positive differentiation for effectiveness and convenience which we believe will address unmet needs in the market. For the U.S. label, Elanco now expects a boxed warning on safety stemming from a trial with unvaccinated dogs dosed at 3x the dose that will slow the product adoption curve in the U.S. and initially limit the number of expected treatment days. Elanco remains confident in the product’s blockbuster potential. Zenrelia has also received its first full approval in Brazil. The product is now expected to launch in both the US and Brazil in the fourth quarter of 2024. “We have a robust innovation portfolio and continue to expect to deliver $600 million to $700 million of Innovation sales by the end of 2025,” said Jeff Simmons, Elanco President and CEO. “With the expected launches of Bovaer and Zenrelia in the second half and the continued strong performance of Experior and AdTab, we are increasing our expectations of Innovation sales in 2024 from $375 to $410 million to $400 to $450 million.” https://bit.ly/45IAXIg

    Elanco Provides Innovation Update

    Elanco Provides Innovation Update

    elanco.com

  • View organization page for Elanco, graphic

    292,498 followers

    Healthy animals are central to global sustainability objectives. In 2022, in partnership with GALVmed and with support from the Bill & Melinda Gates Foundation, we launched Managing Animal Health and Acaricides for a Better Africa (MAHABA) – an initiative to help address this issue by bringing a comprehensive product portfolio to farmers in Uganda and Nigeria, alongside training initiatives focused on addressing the resistance of ticks to acaricides. In this article, Maria Chavez, Advisor Shared Value, explains why collaboration is critical for sustaining the livelihoods of cattle keepers in Uganda. https://bit.ly/3zb5emK #WeAreElanco #SustainableAgriculture

    How Collaborations Can Revolutionize Tick Control in Sub-Saharan Africa – Uganda's Example

    How Collaborations Can Revolutionize Tick Control in Sub-Saharan Africa – Uganda's Example

    elanco.com

  • View organization page for Elanco, graphic

    292,498 followers

    As part of our commitment to enriching the lives of animals and humans alike, our team in Monheim, Germany, recently took a proactive step towards making a difference. Last week, approximately 50 members of our team participated in a run/walk event, with the goal of raising funds for VITA Assistance Dogs, a local non-profit organization that focuses on training service dogs to assist individuals with disabilities. Service dogs are more than just pets; they are lifelines, companions and helpers in the truest sense who help make life better. #WeAreElanco

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • View organization page for Elanco, graphic

    292,498 followers

    Sustainability is a journey, not a destination and our poultry team is helping lead the way. Last week, the team brought together industry leaders for the “Optimizing Feed and Performance – Paving the way to Sustainability in Poultry Industry” summit. Many important topics were discussed including the impact of diet and nutrition on carbon emissions and the opportunities that lay ahead as we move towards a more sustainable future. #WeAreElanco #Poultry #Sustainability

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image

Affiliated pages

Similar pages

Browse jobs

Funding

Elanco 2 total rounds

Last Round

Post IPO equity

US$ 250.0M

Investors

Ancora
See more info on crunchbase